These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1477491)

  • 1. A double-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders.
    Singh I; Owino WJ
    J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():541-9. PubMed ID: 1477491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG; Khan SY; Kumarajeewa DI; Shivanathan S; Veall RM; Wiley YV
    Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients.
    Malt UF; Nystad R; Bache T; Noren O; Sjaastad M; Solberg KO; Tønseth S; Zachariassen P; Maehlum E
    Br J Psychiatry; 1995 Mar; 166(3):374-7. PubMed ID: 7788130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of aggressive behavior problems in boys with intellectual disabilities using zuclopenthixol.
    Hässler F; Dück A; Jung M; Reis O
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):579-81. PubMed ID: 25514543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing of neuroleptics in elderly demented patients with aggressive and agitated behaviour: a double-blind study with zuclopenthixol.
    Nygaard HA; Bakke K; Brudvik E; Elgen K; Lien GK
    Curr Med Res Opin; 1994; 13(4):222-32. PubMed ID: 7882702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours: discontinuation study.
    Haessler F; Glaser T; Beneke M; Pap AF; Bodenschatz R; Reis O;
    Br J Psychiatry; 2007 May; 190():447-8. PubMed ID: 17470962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute functional psychoses: treatment with zuclopenthixol dihydrochloride ('Clopixol') tablets.
    Bhattacharyya SN; Ghoshal J; Sharma SK; Halstead N; John B; Launer MA; Mukherjee PK; Zigmond AS
    Pharmatherapeutica; 1987; 5(1):1-8. PubMed ID: 3602019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
    Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
    Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zuclopenthixol on aggressive disruptive behavior in adults with mental retardation--a 2-year follow-up on a withdrawal study.
    Hässler F; Glaser T; Reis O
    Pharmacopsychiatry; 2011 Nov; 44(7):339-43. PubMed ID: 21993867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: an open-label study.
    Spivak B; Mozes T; Mester R; Kodelik M; Weizman A
    J Child Adolesc Psychopharmacol; 2001; 11(3):279-84. PubMed ID: 11642477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour.
    Schwarz V; Reis O; Glaser T; Thome J; Hiemke C; Haessler F
    Pharmacopsychiatry; 2014 Jan; 47(1):29-32. PubMed ID: 24307207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
    Fuglum E; Schillinger A; Andersen JB; Belstad BE; Jensen D; Müller F; Müller KJ; Schulstad B; Elgen K
    Pharmatherapeutica; 1989; 5(5):285-91. PubMed ID: 2568639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using venlafaxine to treat behavioral disorders in patients with autism spectrum disorder.
    Carminati GG; Gerber F; Darbellay B; Kosel MM; Deriaz N; Chabert J; Fathi M; Bertschy G; Ferrero F; Carminati F
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():85-95. PubMed ID: 26361994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zuclopenthixol and haloperidol in patients with acute psychotic states. A double-blind, multi-centre study.
    Heikkilä L; Eliander H; Vartiainen H; Turunen M; Pedersen V
    Curr Med Res Opin; 1992; 12(9):594-603. PubMed ID: 1582239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
    Nygaard HA; Fuglum E; Elgen K
    Curr Med Res Opin; 1992; 12(10):615-22. PubMed ID: 1353014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.
    Mann BS; Moslehuddin KS; Owen RT; Clayton AR; Rohatgi KK; Sud P; Vaddadi KS
    Pharmatherapeutica; 1985; 4(6):387-92. PubMed ID: 2867559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.
    Huttunen MO; Piepponen T; Rantanen H; Larmo I; Nyholm R; Raitasuo V
    Acta Psychiatr Scand; 1995 Apr; 91(4):271-7. PubMed ID: 7542829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.
    Hässler F; Glaser T; Pap AF; Beneke M; Diefenbacher A; Reis O;
    Pharmacopsychiatry; 2008 Nov; 41(6):232-9. PubMed ID: 19067260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.